PMC:7289100 / 41234-41291 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T166","span":{"begin":5,"end":7},"obj":"Chemical"}],"attributes":[{"id":"A166","pred":"chebi_id","subj":"T166","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A167","pred":"chebi_id","subj":"T166","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"Anti-IL-6 receptor antibodies – Tocilizumab and Sarilumab"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T553","span":{"begin":5,"end":9},"obj":"PR:000001393"},{"id":"T554","span":{"begin":19,"end":29},"obj":"GO:0042571"},{"id":"T555","span":{"begin":32,"end":43},"obj":"DG_35"},{"id":"T556","span":{"begin":48,"end":57},"obj":"DG_39"},{"id":"T88018","span":{"begin":5,"end":9},"obj":"PR:000001393"},{"id":"T87452","span":{"begin":19,"end":29},"obj":"GO:0042571"},{"id":"T52574","span":{"begin":32,"end":43},"obj":"DG_35"},{"id":"T70356","span":{"begin":48,"end":57},"obj":"DG_39"}],"text":"Anti-IL-6 receptor antibodies – Tocilizumab and Sarilumab"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1380","span":{"begin":32,"end":43},"obj":"Chemical"},{"id":"1381","span":{"begin":48,"end":57},"obj":"Chemical"}],"attributes":[{"id":"A1380","pred":"tao:has_database_id","subj":"1380","obj":"MESH:C502936"},{"id":"A1381","pred":"tao:has_database_id","subj":"1381","obj":"MESH:C000592401"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Anti-IL-6 receptor antibodies – Tocilizumab and Sarilumab"}